Bridgebio Oncology Therapeutics, Inc. (BBOT)
2.62
-0.08
(-2.96%)
USD |
NASDAQ |
Oct 30, 16:00
2.64
+0.02
(+0.76%)
After-Hours: 20:00
Bridgebio Oncology Therapeutics EPS Diluted (Quarterly) : -705.20 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -705.20 |
| March 31, 2026 | -526.11 |
| December 31, 2025 | -0.485 |
| September 30, 2025 | -1.029 |
| June 30, 2025 | -566.46 |
| March 31, 2025 | -54.23 |
| Date | Value |
|---|---|
| December 31, 2024 | -1075.56 |
| September 30, 2024 | -0.7369 |
| June 30, 2024 | 0.0941 |
| March 31, 2024 | 0.0468 |
| December 31, 2023 | -0.002 |
| December 31, 2022 | -0.0002 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | -2.890 |
| IRulya Therapeutics, Inc. | -12.31 |
| PepGen Inc. | -0.2574 |
| Q32 Bio, Inc. | -0.4398 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -56.45M |
| Total Expenses (Quarterly) | 56.45M |
| Enterprise Value | -13.30M |
| Earnings Yield | -47.05K% |
| Normalized Earnings Yield | -47054.49 |